Related references
Note: Only part of the references are listed.Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma
Evangelia Peponi et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma
Martina Rudelius et al.
BLOOD (2006)
Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB
DD Sarbassov et al.
MOLECULAR CELL (2006)
Rapamycin inhibits hTERT telomerase mRNA expression, independent of cell cycle arrest
VL Bae-Jump et al.
GYNECOLOGIC ONCOLOGY (2006)
Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis
M Cully et al.
NATURE REVIEWS CANCER (2006)
Perturbations of the AKT signaling pathway in human cancer
DA Altomare et al.
ONCOGENE (2005)
Gene expression profiling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3K-AKT, WNT and TGFβ signalling pathways
EG Rizzatti et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Proteomic analysis of mantle-cell lyrnphoma by protein microarray
IM Ghobrial et al.
BLOOD (2005)
Constitutive activation of phosphatidyl-inositide 3 kinase contributes to the survival of Hodgkin's lymphoma cells through a mechanism involving Akt kinase and mTOR
A Dutton et al.
JOURNAL OF PATHOLOGY (2005)
Role of glycogen synthase kinase 3β in rapamycin-mediated cell cycle regulation and chemosensitivity
JJ Dong et al.
CANCER RESEARCH (2005)
Inhibition of Akt increases P27KiP1 levels and induces cell cycle arrest in anaplastic large cell lymphoma
GZ Rassidakis et al.
BLOOD (2005)
Elevated S-phase kinase-associated protein 2 protein expression in acute myelogenous leukemia: Its association with constitutive phosphorylation of phosphatase and tensin homologue protein and poor prognosis
YH Min et al.
CLINICAL CANCER RESEARCH (2004)
Induction of hTERT expression and phosphorylation by estrogen via Akt cascade in human ovarian cancer cell lines
A Kimura et al.
ONCOGENE (2004)
Phosphatase and tensin homologue phosphorylation in the C-terminal regulatory domain is frequently observed in acute myeloid leukaemia and associated with poor clinical outcome
JW Cheong et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Regulation of telomerase activity and anti-apoptotic function by protein-protein interaction and phosphorylation
J Haendeler et al.
FEBS LETTERS (2003)
Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27Kip1 by PKB/Akt-mediated phosphorylation in breast cancer
G Viglietto et al.
NATURE MEDICINE (2002)
PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest
J Liang et al.
NATURE MEDICINE (2002)
Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control
R Loewith et al.
MOLECULAR CELL (2002)
Negative feedback regulation of the tumor suppressor PTEN by phosphoinositide-induced serine phosphorylation
D Birle et al.
JOURNAL OF IMMUNOLOGY (2002)
Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex
F Vazquez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
A CDK-independent function of mammalian Cks1:: Targeting of SCFSkp2 to the CDK inhibitor p27Kip1
C Spruck et al.
MOLECULAR CELL (2001)
The cell-cycle regulatory protein Cks1 is required for SCFSkp2-mediated ubiquitinylation of p27
D Ganoth et al.
NATURE CELL BIOLOGY (2001)
Human immunodeficiency virus type 1 modulates telomerase activity in peripheral blood lymphocytes
G Ballon et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Phosphorylation of the PTEN tail regulates protein stability and function
F Vazquez et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1
RH Medema et al.
NATURE (2000)
Share Paper
